Stock Track | Bausch Health Stock Surges 7.27% After Hours on Strong Q3 Earnings Beat

Stock Track10-30

Shares of Bausch Health Companies Inc (BHC) soared 7.27% in after-hours trading on Wednesday following the release of its better-than-expected third-quarter earnings report. The pharmaceutical company's strong financial performance exceeded analyst estimates, driving investor enthusiasm.

Bausch Health reported quarterly earnings of $1.16 per share, surpassing the analyst consensus estimate of $1.13 by 2.38%. This represents a notable improvement from the same period last year when the company posted earnings of $1.12 per share. Additionally, Bausch Health's quarterly sales reached $2.681 billion, beating the analyst consensus estimate of $2.637 billion by 1.66%. The company's revenue showed a solid 6.81% increase compared to $2.510 billion in the same quarter of the previous year.

The impressive earnings results demonstrate Bausch Health's ability to navigate challenges in the pharmaceutical industry and deliver growth. Investors appear to be reacting positively to the company's financial strength and operational efficiency. As the stock market digests this information, it will be interesting to see if Bausch Health can maintain this momentum in the coming trading sessions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147005318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147005318","market":"nz","top_or_hot":-1,"title":"Stock Track | Bausch Health Stock Surges 7.27% After Hours on Strong Q3 Earnings Beat","media":"Stock Track","content":"<p>Shares of Bausch Health Companies Inc (BHC) soared 7.27% in after-hours trading on Wednesday following the release of its better-than-expected third-quarter earnings report. The pharmaceutical company's strong financial performance exceeded analyst estimates, driving investor enthusiasm.</p>\n\n<p>Bausch Health reported quarterly earnings of $1.16 per share, surpassing the analyst consensus estimate of $1.13 by 2.38%. This represents a notable improvement from the same period last year when the company posted earnings of $1.12 per share. Additionally, Bausch Health's quarterly sales reached $2.681 billion, beating the analyst consensus estimate of $2.637 billion by 1.66%. The company's revenue showed a solid 6.81% increase compared to $2.510 billion in the same quarter of the previous year.</p>\n\n<p>The impressive earnings results demonstrate Bausch Health's ability to navigate challenges in the pharmaceutical industry and deliver growth. Investors appear to be reacting positively to the company's financial strength and operational efficiency. As the stock market digests this information, it will be interesting to see if Bausch Health can maintain this momentum in the coming trading sessions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bausch Health Stock Surges 7.27% After Hours on Strong Q3 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bausch Health Stock Surges 7.27% After Hours on Strong Q3 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-30 04:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Bausch Health Companies Inc (BHC) soared 7.27% in after-hours trading on Wednesday following the release of its better-than-expected third-quarter earnings report. The pharmaceutical company's strong financial performance exceeded analyst estimates, driving investor enthusiasm.</p>\n\n<p>Bausch Health reported quarterly earnings of $1.16 per share, surpassing the analyst consensus estimate of $1.13 by 2.38%. This represents a notable improvement from the same period last year when the company posted earnings of $1.12 per share. Additionally, Bausch Health's quarterly sales reached $2.681 billion, beating the analyst consensus estimate of $2.637 billion by 1.66%. The company's revenue showed a solid 6.81% increase compared to $2.510 billion in the same quarter of the previous year.</p>\n\n<p>The impressive earnings results demonstrate Bausch Health's ability to navigate challenges in the pharmaceutical industry and deliver growth. Investors appear to be reacting positively to the company's financial strength and operational efficiency. As the stock market digests this information, it will be interesting to see if Bausch Health can maintain this momentum in the coming trading sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHC","symbol_name":"Bausch Health Companies Inc","start_time":0,"source_url":"","article_id":"1147005318","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147005318","pubTimestamp":1761769983,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Bausch Health Companies Inc (BHC) soared 7.27% in after-hours trading on Wednesday following the release of its better-than-expected third-quarter earnings report. The pharmaceutical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BHC":"Bausch Health Companies Inc"},"translate_title":"个股追踪|第三季度盈利强劲，博士生健康股价盘后大涨7.27%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHC":1},"content_text":"Shares of Bausch Health Companies Inc (BHC) soared 7.27% in after-hours trading on Wednesday following the release of its better-than-expected third-quarter earnings report. The pharmaceutical company's strong financial performance exceeded analyst estimates, driving investor enthusiasm.\nBausch Health reported quarterly earnings of $1.16 per share, surpassing the analyst consensus estimate of $1.13 by 2.38%. This represents a notable improvement from the same period last year when the company posted earnings of $1.12 per share. Additionally, Bausch Health's quarterly sales reached $2.681 billion, beating the analyst consensus estimate of $2.637 billion by 1.66%. The company's revenue showed a solid 6.81% increase compared to $2.510 billion in the same quarter of the previous year.\nThe impressive earnings results demonstrate Bausch Health's ability to navigate challenges in the pharmaceutical industry and deliver growth. Investors appear to be reacting positively to the company's financial strength and operational efficiency. As the stock market digests this information, it will be interesting to see if Bausch Health can maintain this momentum in the coming trading sessions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147005318","isCrawlerRequest":true}